Hence, all these findings provide experimental evidence for a model whereby Nedd4l exerts its tumor suppressor roles largely by inhibiting the CTR1‐AKT signaling pathway in a copper‐PDK1 binding dependent manner (Figure 7). The gene discussed is NEDD4L; the disease is neoplasm.